Skip to main content

Year: 2025

Aardvark Therapeutics Reports Third Quarter 2025 Financial Results and Provides Pipeline and Business Updates

Aardvark has aligned with the FDA to reduce the minimum age of eligibility from 13 to 10 years old for pediatric patients in HERO, the Phase 3 trial of ARD-101 for the treatment of hyperphagia associated with Prader-Willi Syndrome (PWS) New preclinical data presented at ObesityWeek 2025 demonstrates the potential of ARD-201 in enhanced glucose control, along with preservation of lean body mass, underscoring its opportunity in addressing key challenges in today’s obesity treatment landscape Oral ARD-201 shows potential for weight management after GLP-1RA discontinuation, supported by new promising preclinical results and ARD-101 clinical data $126.4 million in cash, cash equivalents, and short-term investments as of September 30, 2025, supports projected operations into 2027 SAN DIEGO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Aardvark...

Continue reading

Intchains Group Limited Reports Third Quarter and Nine Months 2025 Financial Results

Launches New High-Performing XTM Mining Products to Support Revenue Growth in Q4 2025 Initiates ETH Staking with FalconX with Initial 1,000 ETH in Place Acquisition of Proof-of-Stake Platform to Advance Cryptocurrency Staking Business SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Intchains Group Limited (Nasdaq: ICG) (“we,” or the “Company”), a company engaged in the provision of altcoin mining products, strategic acquisition and holding of Ethereum-based cryptocurrencies, and active development of innovative Web3 applications, today announced its unaudited financial results for the third quarter (“Q3 2025”) and nine months (“9M 2025”) ended September 30, 2025. Q3 2025 FINANCIAL HIGHLIGHTSRevenue: Revenue was RMB9.1 million (US$1.3 million), compared to RMB60.3 million for the same period of 2024. Income/(Loss) from Operations:...

Continue reading

Equillium Reports Third Quarter 2025 Financial Results and Provides Operational Update

Closed financing of up to $50 million; initial tranche of $30 million provides runway through 2027 Hosted key opinion leader event highlighting the important role of the Aryl Hydrocarbon Receptor (AhR) in intestinal inflammation, the unmet medical need in ulcerative colitis, and the potential clinical utility of EQ504, a novel oral AhR modulator EQ504 Phase 1 clinical study initiation planned for mid-2026 LA JOLLA, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced financial results for its third fiscal quarter ended September 30, 2025. The Company has filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange...

Continue reading

Jefferson Capital Reports Third Quarter 2025 Results

Collections Grow 63% to $236.8 Million and Deployments Grow 22% to $151.0 MillionPre-tax Income up 16% to $45.5 Million with Net Income of $38.4 Million and EPS of $0.59Adjusted Pre-tax Income up 30% to $54.8 Million with Adjusted Net Income of $47.7 Million and Adjusted EPS of $0.74Board of Directors Declares Quarterly Cash Dividend of $0.24 per Share MINNEAPOLIS, Nov. 13, 2025 (GLOBE NEWSWIRE) — Jefferson Capital, Inc. (“Jefferson Capital”), a leading analytically driven purchaser and manager of charged-off, insolvency and active consumer accounts, today announced its third quarter 2025 financial results. “We delivered strong third quarter results with significant momentum in all key aspects of the business,” said David Burton, Chairman and Chief Executive Officer. “We continue to execute well on our differentiated strategy and...

Continue reading

Freehold Royalties Announces Third Quarter 2025 Results

CALGARY, Alberta, Nov. 13, 2025 (GLOBE NEWSWIRE) — Freehold Royalties Ltd. (Freehold or the Company) (TSX:FRU) announces third quarter results for the period ended September 30, 2025. Third Quarter Highlights$74 million in revenue; $59 million in funds from operations ($0.36/share) (1)(2); $44 million in dividends paid ($0.27/share)(3); 16,054 boe/d(4) of total production, a 10% increase from the third quarter of 2024; 10,477 bbls/d of total crude oil and natural gas liquids production, a 12% increase from the third quarter 2024; 65% liquids weighting, an increase from 64% in the third quarter of 2024; Gross drilling of 282 wells, comprised of 83 wells in Canada and 199 in the U.S. similar levels to the third quarter 2024; Continued active leasing program with 34 new leases signed (27 in Canada; 7 in the U.S.) contributing revenue...

Continue reading

The Air Canada Foundation Accepting Applications for 2026 Grants

Requests must be submitted by a Canadian registered charity Grants applications will close December 31, 2025 In 2025, the Air Canada Foundation disbursed $1.6 million in support of 38 projects supporting childrenMONTRÉAL, Nov. 13, 2025 (GLOBE NEWSWIRE) — The Air Canada Foundation is excited to welcome applications to its annual grant program. Through this initiative, the Foundation remains deeply committed to improving the health and well-being of children and youth by funding programs that deliver meaningful, lasting impact on children and their families from coast to coast to coast.Applicants must demonstrate how their proposed project or program will improve and increase access to care, services and eliminate barriers to foster the overall well-being for children and youth from underserved* populations. To be eligible for...

Continue reading

Security National Financial Corporation Reports Financial Results for the Quarter Ended September 30, 2025

SALT LAKE CITY, Nov. 13, 2025 (GLOBE NEWSWIRE) — Security National Financial Corporation (SNFC) (NASDAQ symbol “SNFCA”) announced financial results for the quarter ended September 30, 2025. For the three months ended September 30, 2025, SNFC’s after tax earnings decreased 34% from $11,831,000 in 2024 to $7,815,000 in 2025. For the nine months ended September 30, 2025, after tax earnings decreased 30% to $18,866,000 from $26,578,000 in 2024. Scott M. Quist, President of the Company, said: “While the third quarter was definitely weak from my point of view, being $4MM below Q3 2024 or roughly 34%, there are some definite bright spots which partially illuminate much of the hard work that has gone on. For example, on a Return On Equity basis, as of September 30th we achieved a 7.9% ROE for the nine months, which if annualized...

Continue reading

Bavarian Nordic Announces Changes to the Board of Directors

COPENHAGEN, Denmark, November 13, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Chair of the Board, Luc Debruyne has decided to step down from the board with immediate effect. The Board has appointed Vice Chair Anne Louise Eberhard as new Chair of the Board. “After careful reflection on both the process and the outcome of the recent takeover attempt, I have decided to step down to enable the board of Bavarian Nordic to focus on the company’s next phase of development. I have deep appreciation for the company’s remarkable achievements throughout its transformation in recent years and I take pride in having led the board during such a dynamic and important period. I extend my heartfelt thanks and best wishes to the management team and all employees for their dedication and professionalism as they continue to strengthen the...

Continue reading

Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025

Haverford, PA, Nov. 13, 2025 (GLOBE NEWSWIRE) — Investview, Inc. (OTCQB: INVU), a diversified financial technology services company operating across multiple business units that feature the sale of financial education products and services through a global network of independent distributors, the manufacture and sale of consumer health, wellness and nutrition products, an early-stage online trading broker-dealer platform for self-directed retail investors, and a sustainable blockchain technology focused on Bitcoin mining and related infrastructure, reported its financial results today for the third quarter ended September 30, 2025, as well as shared highlights of key operational progress, strategic milestones, and forward-focused initiatives. Summary Consolidated Financial Highlights: Results of Operations and Cash Flow Data-Three...

Continue reading

Chijet Motor Company Inc. Announces Official Name Change to “Digital Currency X Technology Inc.” and New Ticker Symbol “DCX” Effective November 14, 2025

New York, Nov. 13, 2025 (GLOBE NEWSWIRE) — CHIJET MOTOR COMPANY, INC. (NASDAQ: CJET) (the “Company”) today announced that effective at the opening of trading on November 14, 2025, the Company’s Class A ordinary shares will begin trading on the Nasdaq Capital Market under the new name “Digital Currency X Technology Inc.” and new ticker symbol “DCX.” On September 24, 2025, the Company’s shareholders voted and approved at the annual general meeting that subject to and conditional upon the approval of the Registrar of Companies in the Cayman Islands (the “Cayman Registrar”), the name of the Company be changed from “CHIJET MOTOR COMPANY, INC.” to “Digital Currency X Technology Inc.”, with effect from the date of the certificate of incorporation on change of name to be issued by the Cayman Registrar (the “Change of Name”). Upon the effectiveness...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.